Abvc biopharma engaged by orion biotech to identify global licensing partners

Fremont, ca, may 25, 2022 (globe newswire) -- via newmediawire – abvc biopharma, inc. (nasdaq: abvc), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today announced that it has been engaged by orion biotech, inc., a medical device company based in taipei, taiwan, to identify candidates interested in out-licensing orion developmental products, such as orion's “lamina cover” for spine surgery, its “wireless intracranial pressure (icp) monitor” for brain surgery and its “auto-stop drill” for orthopedic surgery. the lamina cover recently received u.s. f.d.a. medical device 510(k) approval.
ABVC Ratings Summary
ABVC Quant Ranking